Equities

Create Bookmark Delete Bookmark Create Alert Delete Alert

IFR US ECM Calendar

 |  Robert Sherwood

April 14: Allogene Therapeutics (US, biotech) ─ $175m FO. Fixed size (Primary) versus $3.06 at launch. GS, JEFF, TDC. 

April 14: Revolution Medicines (US, biotech) ─ $750m FO. Fixed size (Primary) versus $136.30 at launch. JPM, TDC, GUGG. Concurrent $250m 7y CB. 

April 14: Revolution Medicines (US, biotech) ─ $250m 7y cvt marketed at 1%-1.5%, up 37.5%-42.5%. JPM, TDC, GUGG. Concurrent $750m follow-on offering. 

April 14: Spyre Therapeutics (US, biotech) ─ $300m FO. Fixed size (Primary) versus $63.27 at launch. JEFF, GS, EVER, GUGG. 

April 15: Arxis (US, aerospace and defense) ─ $1.06bn IPO. 37.7m shares (Primary) at $25-$28. GS, MS, JEFF. Nasdaq "ARXS". Capital International, Capital Research Global, Janus Henderson and T Rowe Price have indicated for $400m combined of the offering. 5% DSP. 

April 15: Madison Air Solutions (US, industrial) ─ $2.23bn IPO. 82.7m shares (Primary) at $25-$27. GS, BARC, JEFF, WF. NYSE “MAIR”. Morgan Stanley Investment Management, Durable Capital and HRTG have indicated for $525m combined of the offering. Founder Larry Gies purchasing $100m of Class B shares through concurrent private placement. 

April 16: Aevex (US, aerospace and defense) ─ $336m IPO. 16m shares (Primary, Secondary) at $18-$21. GS, BOFA, JEFF. NYSE "AVEX". Madison Dearborn is the controlling shareholder. 5% DSP. 

April 16: Alamar Biosciences (US, medtech) ─ $159.4m IPO. 9.4m shares (Primary) at $15-$17. JPM, BOFA, TDC, LEER, STFL. Nasdaq “ALMR”. 

April 16: Kailera Therapeutics (US, biotech) ─ $533.3m IPO. 33.3m shares (Primary) at $14-$16. JPM, JEFF, LEER, TDC, EVER. Nasdaq “KLRA”. Affiliates of Bain Capital and Qatar Investment Authority have indicated for up to $225m combined of offering upfront. 

April 21: National Healthcare Properties (US, senior housing REIT) ─ $616m IPO. 38.5m shares (Primary) at $13-$16. WF, MS, BMO, GS, RBC. Nasdaq “NHP”. 

April 21: Yesway (US, convenience store chain) ─ $320.9m IPO. 13.95m shares (Primary) at $20-$23. MS, JPM, GS. Nasdaq “YSWY”. 5% DSP. 

April 28: Pershing Square USA (US, closed-end fund) ─ $5bn-$10bn IPO. 100m-200m shares (Primary) marketed at $50.00 fixed price. CITI, UBS, BOFA, JEFF, WF. NYSE “PS”. Concurrent $2.8bn private placement indicated for at launch. Concurrent distribution of 20 shares in Pershing Square Asset Management per 100 shares purchased in IPO.